Coronary artery endarterectomy: a method of myocardial preservation

R H Johnston1, R Garcia-Rinaldi, M J Wall

  • 1DeBakey Heart Institute, Kenosha, WI 53143.

Texas Medicine
|June 1, 1993
PubMed

Insights

Coronary endarterectomy combined with bypass surgery offers a solution for severe coronary artery disease when grafts are unavailable. This technique allows for longer ischemic times and improved arterial clearance in high-risk patients.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Severe coronary artery disease (CAD) poses challenges when suitable coronary arteries for grafting are unavailable.
  • Standard bypass surgery may be insufficient for patients with extensive arterial disease and debris.
  • Alternative strategies are needed to manage complex CAD cases effectively.

Purpose of the Study:

  • To evaluate the efficacy of combining coronary bypass surgery with coronary endarterectomy and retrograde coronary sinus cardioplegia perfusion.
  • To assess the feasibility of this combined approach in patients with near inoperable CAD.
  • To determine the outcomes and mortality rates associated with this technique.

Main Methods:

  • A cohort of 72 patients with near inoperable CAD underwent combined coronary bypass surgery and endarterectomy.
  • Retrograde coronary sinus cardioplegia perfusion was employed to facilitate debris flushing and extend ischemic time.
  • Endarterectomy was performed on single or multiple vessels as needed, with a focus on the left coronary artery system.

Main Results:

  • The combined approach successfully managed 72 high-risk patients, with one-third requiring multi-vessel endarterectomy.
  • A significant proportion of patients had diabetes mellitus, and nearly 60% underwent left coronary artery endarterectomy.
  • The mortality rate for left system endarterectomy was 5.7%.

Conclusions:

  • Coronary endarterectomy, as an adjunct to bypass surgery, is a viable option for managing high-risk patients with severe CAD.
  • The combined technique, including retrograde perfusion, can extend ischemic times and clear arterial debris.
  • This approach expands treatment possibilities for patients with limited grafting options.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...